Oral Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Efficacy Study of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers
Condition:   Oral Mucositis Interventions:   Drug: RRx-001;   Radiation: Intensity Modulated Radiation Therapy (IMRT);   Drug: Cisplatin for injection 100 mg/m2 Sponsor:   EpicentRx, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
Conditions:   Mesothelioma;   Malignant Mesothelioma (MM);   Early-stage Mesothelioma;   Subclinical Mesothelioma;   BRCA1-Associated Protein-1 (BAP1) Mutations;   Early-stage BAP1-associated Malignancies Intervention:   Drug: Decitabine/cedazuridine Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials